Literature DB >> 414528

The effect of topically applied agents on ultraviolet erythema in guinea pigs.

P Peters, C Cooper, K Maiorana, M L Graeme.   

Abstract

It has been shown previously that ultraviolet erythema (UV) is partially the result of a local release of prostaglandins. We have studied the effects of different classes of pharmacological agents applied topically to the skin of guinea pigs and have found indomethacin and pirprofen, both prostaglandin synthetase inhibitors, to be highly effective suppressors of UV erythema. Our studies appear to further substantiate that prostaglandin synthesis and release may be the primary mechanistic process in the production of erythema and that the model itself can be predictive of both therapeutic and prophylactic effects of agents against sunburn.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 414528     DOI: 10.1007/bf02111128

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  17 in total

Review 1.  Prostaglandins and cutaneous inflammation.

Authors:  M E Goldyne
Journal:  J Invest Dermatol       Date:  1975-06       Impact factor: 8.551

2.  Interactions of aspirin with nonsteroidal antiinflammatory drugs in man.

Authors:  A Rubin; B E Rodda; P Warrick; C M Gruber; A S Ridolfo
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

3.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

4.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

5.  Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat.

Authors:  C G Van Arman; G W Nuss; E A Risley
Journal:  J Pharmacol Exp Ther       Date:  1973-11       Impact factor: 4.030

6.  Influence of corticosteroids on ultraviolet light erythema and pigmentation in man.

Authors:  B Ljunggren; H Möller
Journal:  Arch Dermatol Forsch       Date:  1973

7.  Pharmacologic agents released in ultraviolet inflammation studied by continuous skin pefusion.

Authors:  M W Greaves; J Sondergaard
Journal:  J Invest Dermatol       Date:  1970-05       Impact factor: 8.551

8.  Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats.

Authors:  D W Yesair; L Remington; M Callahan; C J Kensler
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

9.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

10.  Recovery of prostaglandins in human cutaneous inflammation.

Authors:  M W Greaves; J Sondergaard; W McDonald-Gibson
Journal:  Br Med J       Date:  1971-05-01
View more
  8 in total

1.  Anti-inflammatory activity of orpanoxin administered orally and topically to rodents.

Authors:  R R Brooks; K R Bonk; G E Decker; K E Miller
Journal:  Agents Actions       Date:  1985-07

2.  The anti-inflammatory profile of dapsone in animal models of inflammation.

Authors:  A J Lewis; D K Gemmell; W H Stimson
Journal:  Agents Actions       Date:  1978-12

3.  QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents.

Authors:  E J Lien; H Gao
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 4.  Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; R Beresford
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

5.  The relationship between development of ultraviolet erythema and release of prostaglandins in guinea pig skin.

Authors:  S S Adams; R G Humphries; C G Mason
Journal:  Agents Actions       Date:  1981-11

6.  The Arthus reaction in rats, a possible test for anti-inflammatory and antiheumatic drugs.

Authors:  L R Pflum; M L Graeme
Journal:  Agents Actions       Date:  1979-06

Review 7.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 8.  Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.